Bal Pharma Limited announced the Resignation of Mr. G. Rengarajan as Chief Financial Officer (CFO) as CFO of the Company from the closure of business hours on November 24, 2022. The resignation is purely on account of health reason and other personal commitments and there are no other material reasons than the one mentioned herewith.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
101.1 INR | +0.96% | +4.59% | +0.64% |
1st Jan change | Capi. | |
---|---|---|
+0.64% | 18.85M | |
+26.07% | 661B | |
+26.74% | 566B | |
-6.46% | 352B | |
+18.74% | 332B | |
+3.83% | 283B | |
+13.43% | 231B | |
+4.71% | 200B | |
-9.53% | 195B | |
-4.10% | 145B |
- Stock Market
- Equities
- BALPHARMA Stock
- News Bal Pharma Limited
- Bal Pharma Limited Announces Resignation of Mr. G. Rengarajan as Chief Financial Officer